编者按：作为眼科领域的重大国际盛事，Euretina 2023将荟聚全球顶级的视网膜专家，共同探讨视网膜疾病研究的新成果、新进展。本次会议将重点关注常见的视网膜疾病，如糖尿病性视网膜病变、黄斑变性和视网膜脱离等，这些议题不仅受到与会专家的广泛关注，更是全球视觉健康领域的焦点问题。此次会议上，中国眼科学者也将携带具有中国特色的研究成果和经验，亮相国际舞台，为全球视觉健康贡献中国智慧，进一步提升中国眼科领域在国际上的地位和影响力。

中国之声：讲座与自由论文

10月5日

讲题：Evaluation of intraoperative parameters of 3D visualization system for vitreoretinal diseases in highly myopic eyes

3D可视化系统对高度近视玻璃体视网膜疾病术中参数的评估

讲者：Mei-Chi Tsui (Taiwan)

时间：10月5日11:28—11:34 CEST

论坛：Free Paper Session 1: Myopia

地点：Emerald Room

讲题：Clinical and Genetic Features of Familial Exudative Vitreoretinopathy with TSPAN12 Variants in a Large Chinese Cohort

一项大型中国队列研究：家族性渗出性玻璃体视网膜病变伴TSPAN12变异的临床和遗传特征

讲者：Songshan Li (China)

时间：10月5日15:16—15:21 CEST

论坛：Speakers' Corner 3: IRD / Paediatrics I（演讲者之角3: IRD /儿科I）

地点：Speakers Corner

10月7日

讲题：Kreissig Award Lecture :Uveitis:Management with Vitreoretional Surgery?

Kreissig奖演讲：葡萄膜炎——玻璃体视网膜手术治疗?

讲者：Shwu-Jiuan Sheu (Taiwan)

时间：10月7日14:00 CEST

论坛：Kreissig Award Lecture地点：Grand Auditorium

讲题：Activities to avoid high myopia in China in 2023

2023年中国预防高度近视的活动

讲者：Calvin Pang (China)

时间：10月7日9:36 - 9:47 CEST

论坛：Symposium Session 11: High Myopia and How to Avoid it in 2023 EVER Symposium.地点：Auditorium

讲题：DR screening in China: present and future

中国DR筛查的现状与未来

讲者：Xiaoling Liang (China)

时间：10月7日17:23 - 17:30 CEST

论坛：Instructional Course 32: Present and Future of DR Screening Worldwide

地点：Emerald Room

讲题：Efficacy, durability, and safety of faricimab in diabetic macular edema (DME): 1-year results from China subpopulation of phase 3 RHINE trial

法利单抗治疗糖尿病性黄斑水肿（DME）的有效性、耐久性和安全性：来自中国亚群3期RHINE试验的1年结果

讲者：Xiaorong Li (China)

时间：10月7日15:43 - 15:49 CEST

论坛：Free Paper Session 14: Mixed II

地点：E103/104

讲题：Improved Accuracy of Spectral Domain Optical Coherence Tomography Dense Volumetric Scan Together With Optical Coherence Tomography Angiography for Monitoring Myopic Macular Neovascularization Activity

提高光谱域光学相干断层扫描密集体积扫描的准确度，结合光学相干断层扫描血管造影术监测近视黄斑新生血管活动

讲者：Danny Siu-Chun Ng (Hong Kong)

时间：10月7日14:06 - 14:11CEST

论坛：Speakers' Corner 11: Imaging

地点：Speakers Corner

10月8日

讲题：Surgical challenges in congenital paediatric retinal diseases (PHV, morning glory and others)

先天性儿科视网膜疾病（PHV、牵牛花综合征和其他疾病）的外科挑战

讲者：Wei-Chi Wu (Taiwan)

时间：10月8日9:02 - 9:12CEST

论坛：Instructional Course 34: Paediatric Retina: Complications and Challenges

地点：E102

中国之声：电子壁报摘取

讲题：Efficacy, durability, and safety of faricimab in neovascular age-related macular degeneration (nAMD):48-week results from the China subpopulation of the phase 3 LUCERNE trial faricimab

LUCERNE 3期试验中国亚群48周的结果：法利单抗治疗新生血管性年龄相关性黄斑变性的疗效、持久性和安全性

第一作者：Youxin Chen (CHINA)

共同作者：Ming Zhang, MD (CHINA), Dawei Sun, MD, PhD (CHINA), Jeffrey Willis, MD, PhD (US), Ruyuan Liu, MD, PhD (CHINA), Sijing Li, PhD (CHINA), Li Zhang, MD, PhD (CHINA), Vaibhavi Patel, MSc (UK), Aachal Kotecha, PhD (UK)

讲题：Changes of Estimated Glomerular Filtration Rate and Glycated Hemoglobin A1c in Diabetic Macular Edema Patients Treated by Ranibizumab and Aflibercept in the Tertiary Referral Hos-pital

三级转诊医院中接受雷珠单抗和阿柏西普治疗的糖尿病黄斑水肿患者肾小球滤过率和糖化血红蛋白A1c的变化

第一作者：Chun-Ju Lin (TAIWAN)

共同作者：Wei-Ning Ku (TAIWAN), Peng-Tai Tien (TAIWAN), Chun-Chi Chiang (TAIWAN), Ning-Yi Hsia (TAIWAN), Chun-Ting Lai (TAIWAN), Chih-Hsin Muo (TAIWAN), Henry Bair (TAIWAN), Huan-Sheng Chen (TAIWAN), Jane-Ming Lin (TAIWAN), Wen-Lu Chen (TAIWAN), Wen-Lu Chen (TAIWAN), Yi-Yu Tsai (TAIWAN)

讲题：Improved Accuracy of Spectral Domain Optical Coherence Tomography Dense Volumetric Scan Together With Optical Coherence Tomography Angiography for Monitoring Myopic Macular Neovascularization Activity

提高光谱域光学相干断层扫描密集体积扫描的准确度，结合光学相干断层扫描血管造影术监测近视黄斑新生血管活动

第一作者：Danny Siu-Chun Ng (HONG KONG)

共同作者：Li Jia Chen (HONG KONG), Leo Ka Yu Chan (HONG KONG), Wee Min Teh (MALAYSIA), Ka Wai Yuen (HONG KONG), Shaheeda Mohamed (HONG KONG), Chi Wai Tsang (HONG KONG), Xiuyuan Zhang (CHINA), Timothy Y. Y. Lai (HONG KONG)

讲题：Choroidal thickness and regional choroidal vascularity index in Branch Retinal Vein Occlusion

视网膜分支静脉阻塞的脉络膜厚度和区域脉络膜血管指数

第一作者：Han Zhang (CHINA)

共同作者：Yan-Qi Xue (CHINA), Si-Qi Li (CHINA), Xiao-Tong Zhang (CHINA), Bing-Yu Wang (CHINA), Gui-Qi Zhang (CHINA), Iko Hidasa (CHINA)

讲题：Differences in the efficacy of intravitreal Conbercept (IVC) monotherapy or panretinal photocoagulation (PRP) combined with IVC in proliferative diabetic retinopathy patients

玻璃体腔注射康柏西普或全视网膜光凝(PRP)联合玻璃体腔注射康柏西普治疗增生性糖尿病视网膜病变的疗效差异

第一作者：Huijun Qi (CHINA)

共同作者：Yaoyao Sun (CHINA)

讲题：Prognostic Factors in the Treatment of Polypoid Choroidal Vasculopathy with Conbercept: A Post Hoc Analysis of STAR study

STAR研究的事后分析：康柏西普治疗息肉状脉络膜血管病变的预后因素

第一作者：Jinfeng Qu (CHINA)

共同作者：Zongyi Wang (CHINA), Tang Ran (CHINA), Xuan Shi (CHINA), Xin Ying (CHINA), Xiaoxin Li (CHINA)

讲题：Evaluation of 3D heads-up as a training tool for vitrectomy surgery in pediatric patients with persistent fetal vasculature

3D平视手术系统作为玻璃体切除术的训练工具在永存胚胎血管患儿中应用

第一作者：Jinghua Liu (CHINA)共同作者：Hai Lu (CHINA), Songfeng Li (CHINA), Guangda Deng (CHINA), Liang Li (CHINA), Jing Ma (CHINA), Mingzhen Yuan (CHINA)

讲题：Safety and efficacy of human embryonic stem cell-derived retinal pigment epithelium cells for dry age-related macular degeneration patients

人胚胎干细胞源性视网膜色素上皮细胞治疗干性老年黄斑变性患者的安全性和有效性

第一作者：Jinyuan Wang (CHINA)

共同作者：Chuqiao Liang (CHINA), Lei Wang (CHINA), Xuhan Shi (CHINA), Yu Feng (CHINA), Yang Li (CHINA), Liu Wang (CHINA), Yanni Yan (CHINA), Chang Shen (CHINA), Liyun Jia (CHINA), Yang Li (CHINA), Yang Li (CHINA), Jie Hao (CHINA), Wei Li (CHINA), Baoyang Hu (CHINA), Qi Zhou (CHINA), Wenbin Wei (CHINA)

讲题：Comparison of 27-Gauge and 23-Gauge probe in the management of vitreous and subretinal hemorrhage secondary to PCV: results of one week post-operation

术后1周的结果：27G与23G探针治疗PCV继发性玻璃体及视网膜下出血的比较

第一作者：Kang Feng (CHINA)

共同作者：Yaxin Zhang (CHINA), Zhizhong Ma (CHINA)

讲题：Hyperfluorescence of choroidal arteries in peripheral fundus on late-phase ICGA

ICGA造影晚期眼底周边脉络膜动脉呈强荧光

第一作者：Miaoling Li (CHINA)

共同作者：Miaoling Li (CHINA), Xiongze Zhang (CHINA), Feng Wen (CHINA)

讲题：3+Treat-and-Extend versus 3+Pro Re Nata Regimen intravitreal Conbercept injection for Neovascular Age-Related Macular Degeneration: Results from COCOA, a prospective, open label, multicenter and randomized phase IV clinical trial

来自COCOA的前瞻性、开放性对照、多中心和随机IV期临床试验结果：玻璃体腔注射康柏西普的3+T&E方案与3+PRN方案治疗新生血管性年龄相关性黄斑变性

第一作者：Mingwei Zhao (CHINA)

共同作者：Yaoyao Sun (CHINA)

讲题：Intraocular lens tilt and decentration after primary and delayed implantation in phacovitrectomy for rhegmatogenous retinal detachment repair

孔源性视网膜脱离的玻璃体切除术中，一期和二期植入人工晶状体的倾斜和偏心

第一作者：Qingchen Li (CHINA)

共同作者：Rui Liu (CHINA)

讲题：Clinical outcomes of complex rhegmatogenous retinal detachment treated with 25G, 10,000 cpm, beveled-tip cutter probe

25G, 10000cpm斜面玻切头治疗复杂孔源性视网膜脱离的临床疗效

第一作者：Ruiping Gu (CHINA)

共同作者：Jiajie Zhao (CHINA), Jiemei Shi (CHINA), Chunhui Jiang (CHINA)

讲题：Clinical and Genetic Features of Familial Exudative Vitreoretinopathy with TSPAN12 Variants in a Large Chinese Cohort

一项大型中国队列研究：家族性渗出性玻璃体视网膜病变伴TSPAN12变异的临床和遗传特征

第一作者：Songshan Li (CHINA)

共同作者：You Wang (CHINA), Xiaoyan Ding (CHINA)

讲题：Atypical manifestations of acute-onset ocular toxocariasis: a case series

病例系列：急性眼弓形体病的非典型表现

第一作者：Songshan Li (CHINA)

共同作者：Limei Sun (CHINA), Xiaoyan Ding (CHINA)

讲题：Efficacy and safety of different doses of Conbercept for neovascular age-related macular degeneration in low vision patient

不同剂量的康柏西普治疗低视力新生血管性年龄相关性黄斑变性的疗效和安全性

第一作者：Suqin Yu (CHINA)

共同作者：Yuanyuan Zhi (CHINA), Tianwei Qian (CHINA), Yanping Zhou (CHINA), Xun Xu (CHINA)

讲题：Retinal Microvascular Ischemia Associated with COVID-19: multimodal imaging assessments

多模式成像评估：与COVID-19相关的视网膜微血管缺血

第一作者：Suqin Yu (CHINA)

共同作者：Min Zhang (CHINA), Junran Sun (CHINA), Chanchan Wang (CHINA), Li Su (CHINA), Jieqiong Chen (CHINA), Chun Yu (CHINA), Mingqi Wu (CHINA), Xiaodong Sun (CHINA), Yuanyuan Gong (CHINA)

讲题：Double-dose Investigation of Aflibercept in Neovascular Age-related Macular Degeneration (DIANA): A Real-world Study

一项真实世界研究：阿柏西普在新生血管性年龄相关性黄斑变性中的双剂量研究

第一作者：Suqin Yu (CHINA)

共同作者：Min Zhang (CHINA), Xing Liu (CHINA), Yuanyuan Gong (CHINA), Tianwei Qian (CHINA), Hao Zhou (CHINA), Yimin Wang (CHINA), Jiali Wu (CHINA), Chun Yu (CHINA), Mingqi Wu (CHINA), Xiaodong Sun (CHINA), Xiaodong Sun (CHINA)

讲题：Real-world outcomes of two-year Conbercept therapy for diabetic macular edema

康柏西普治疗糖尿病性黄斑水肿2年的真实世界结果

第一作者：Tong Qian (CHINA)

讲题：Efficacy, durability, and safety of faricimab in diabetic macular edema (DME): 1-year results from China subpopulation of phase 3 RHINE trial

来自中国3期RHINE试验亚群的1年结果：法利单抗治疗糖尿病黄斑水肿(DME)的有效性、持久性和安全性

第一作者：Xiaorong Li (CHINA)

共同作者：Xiaodong Sun (CHINA), Qin Jiang (CHINA), Xiaoling Liu (CHINA), Oluwatobi Idowu (US), Ruyuan Liu (CHINA), Wenxin Liu (CHINA), Yannan Tang (US), Jeffrey Willis (US), Li Zhang (CHINA), Aachal Kotecha (UK), Aachal Kotecha (UK)

讲题：What Is Left After Resolution of Neonatal Retinal Hemorrhage: The Longitudinal Long-term Outcome in Foveal Structure and Visual Function

新生儿视网膜出血消退后的走向：视网膜中央凹结构和视觉功能的纵向长期结果

第一作者：Xiaoyan Ding (CHINA)

共同作者：Limei Sun (CHINA)

讲题：Comparative evaluation of 10k/25G beveled-tip probe and 5k/23G flat-tip probe in MIVS in day surgery for the treatment of PDR patients with fibrovascular proliferation

10K/25G斜面玻切头与5K/23G玻切头在日间手术治疗PDR纤维血管增生的比较

第一作者：Yanchun Zhang (CHINA)

共同作者：Daxi Xue (CHINA), Ziwei Kang (CHINA)

讲题：Retinal and Choroidal Changes in early-stage Parkinson's disease: from eye to the brain

从眼睛到大脑：早期帕金森病的视网膜和脉络膜变化

第一作者：Yifan Zhang (CHINA)

共同作者：Yifan Zhang (CHINA), Yuzhu Gao (CHINA), Yunhan Tao (CHINA), Hanyue Xu (CHINA), Shulei Man (CHINA), Yi Chen (CHINA), Ming Zhang (CHINA)

讲题：Retinal Manifestations of COVID-19 Infection after the First Pandemic Peak in China: an Alarming Increase in Acute Macular Neuroretinopathy

中国第一个疫情高峰后新冠肺炎感染的视网膜表现：急性黄斑神经视网膜病变数量急速增加

第一作者：Yifan Zhang (CHINA)

共同作者：Yifan Zhang, Yuzhu Gao, Shulei Man, Kefan Mou, Hanyue Xu, Ming Zhang

讲题：Conbercept versus laser therapy for the treatment of infants with Zone II retinopathy of prematurity

康柏西普与激光治疗婴幼儿II区早产儿视网膜病变的比较

第一作者：Yong Cheng (CHINA)

共同作者：Jianhong Liang (CHINA)

讲题：The long-term follow-up of autologous blood clot-assisted lyophilized human amniotic membrane covering treatment unclosed macular hole

自体血凝块辅助冻干人羊膜治疗不闭合性黄斑孔的长期随访

第一作者：Yong Wei (CHINA)

共同作者：Hao Chen (CHINA), Wei Lin (CHINA), Yongpin Tang (CHINA)

讲题：The effect of drainage of suprachoroidal fluid without steroids in the treatment of rhegmatogenous retinal detachment combined with choroidal detachment

无糖皮质激素应用的脉络膜上腔液引流治疗脉络膜脱离性孔源性视网膜脱离的效果观察

第一作者：Yong Wei (CHINA)

共同作者：Wei Lin (CHINA), Hao Chen (CHINA), Yongpin Tang (CHINA)

讲题：Rho-kinase involvement in ocular fibrosisRho

激酶参与眼纤维化

第一作者：Yuebing Li (CHINA)

共同作者：Souska Zandi (GERMANY), Volker Enzmann (GERMANY), Martin Zinkernagel (SWITZERLAND)

讲题：Assessment of alteration in vitreous and retina in patients after SARS-CoV-2 infection using swept-source optical coherence tomography and angiography: a comparative study

一项比较研究：扫描光源光学相干断层扫描和血管造影评估SARS-CoV-2感染后患者玻璃体和视网膜的改变

第一作者：Yuzhu Gao (CHINA)

共同作者：MingZhang (CHINA)

讲题：Retinal structural and microvascular impairments in neuromyelitis optica spectrum disorders and multiple sclerosis: a swept-source optical coherence tomography angiography-based cross-sectional study

一项基于扫频源光学相干断层扫描血管成像的横断面研究：视神经脊髓炎谱系疾病和多发性硬化的视网膜结构和微血管损害

第一作者：Yuzhu Gao (CHINA)

共同作者：MingZhang (CHINA)

因篇幅有限，仅展示部分中国学者信息。

更多学术内容，请持续锁定《国际眼科时讯》，领略更多会议精彩！

声明：本文仅供医疗卫生专业人士了解最新医药资讯参考使用，不代表本平台观点。该等信息不能以任何方式取代专业的医疗指导，也不应被视为诊疗建议，如果该信息被用于资讯以外的目的，本站及作者不承担相关责任。